LOUIS J LAVIGNE JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for LOUIS J LAVIGNE JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of LOUIS J LAVIGNE JR. LOUIS J LAVIGNE JR is Director in ALLERGAN INC ($AGN) and EVP and CFO in GENENTECH INC ($DNA) and Director in DEPOMED INC ($DMI) and Director in ACCURAY INC ($ARAY) and Director in DOCUSIGN INC ($DOCU) and Director in ZYNGA INC ($ZNGA) and Director in Novocure Ltd ($NVCR) and Director in Alector, Inc. ($ALEC).
Latest Insider Trading Transactions of LOUIS J LAVIGNE JR
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAY, ALEC, AGN, DMI, DOCU, DNA, NVCR, ZNGA
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 22 2021 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 6,219 | 0 | 6,219 | |
Feb 22 2021 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 6,219 | 0 | 35,076 | 28.9 K to 35.1 K (+21.55 %) |
Dec 02 2020 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 33,632 | 0 | 282,329 | 248.7 K to 282.3 K (+13.52 %) |
Nov 23 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 6,219 | 0 | 12,438 | |
Nov 23 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 6,219 | 0 | 28,857 | 22.6 K to 28.9 K (+27.47 %) |
Aug 20 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 6,218 | 0 | 18,657 | |
Aug 20 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 6,218 | 0 | 22,638 | 16.4 K to 22.6 K (+37.87 %) |
May 21 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 24,875 | 0 | 24,875 | |
May 13 2020 | ALEC | Alector, Inc. | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 29.09 | 19,274 | 560,681 | 19,274 | |
May 08 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 8,210 | 0 | 0 | |
May 08 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 8,210 | 0 | 16,420 | 8.2 K to 16.4 K (+100.00 %) |
Feb 11 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 8,210 | 0 | 8,210 | |
Feb 11 2020 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 8,210 | 0 | 8,210 | 0 to 8.2 K |
Dec 03 2019 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 48,701 | 0 | 248,697 | 200 K to 248.7 K (+24.35 %) |
Nov 08 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 8,210 | 0 | 16,420 | |
Nov 08 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Gift | G | 0.00 | 8,210 | 0 | 298,081 | 289.9 K to 298.1 K (+2.83 %) |
Nov 08 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Gift | G | 0.00 | 8,210 | 0 | 0 | 8.2 K to 0 (-100.00 %) |
Nov 08 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 8,210 | 0 | 8,210 | 0 to 8.2 K |
Nov 08 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Gift | G | 0.00 | 289,871 | 0 | 289,871 | 0 to 289.9 K |
Nov 08 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Gift | G | 0.00 | 289,871 | 0 | 0 | 289.9 K to 0 (-100.00 %) |
Aug 09 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 8,210 | 0 | 24,630 | |
Aug 09 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 8,210 | 0 | 289,871 | 281.7 K to 289.9 K (+2.91 %) |
Jun 19 2019 | DOCU | DOCUSIGN, INC. | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 3,791 | 0 | 16,542 | 12.8 K to 16.5 K (+29.73 %) |
Jun 19 2019 | DOCU | DOCUSIGN, INC. | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 3,791 | 0 | 16,542 | 12.8 K to 16.5 K (+29.73 %) |
May 14 2019 | ALEC | Alector, Inc. | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 20.05 | 20,000 | 401,000 | 20,000 | |
May 09 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 32,840 | 0 | 32,840 | |
May 09 2019 | DMI | Assertio Therapeut ... | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 31,250 | 0 | 0 | |
May 09 2019 | DMI | Assertio Therapeut ... | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 31,250 | 0 | 58,296 | 27 K to 58.3 K (+115.54 %) |
Apr 30 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 14,535 | 0 | 0 | |
Apr 30 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 14,535 | 0 | 281,661 | 267.1 K to 281.7 K (+5.44 %) |
Feb 11 2019 | ALEC | Alector, Inc. | LAVIGNE LOUIS J JR | Director | Option Exercise | C | 0.00 | 10,552 | 0 | 0 | |
Feb 11 2019 | ALEC | Alector, Inc. | LAVIGNE LOUIS J JR | Director | Buy | C | 0.00 | 10,552 | 0 | 10,552 | 0 to 10.6 K |
Jan 29 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 14,535 | 0 | 14,535 | |
Jan 29 2019 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 14,535 | 0 | 267,126 | 252.6 K to 267.1 K (+5.75 %) |
Dec 06 2018 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 36,585 | 0 | 199,996 | 163.4 K to 200 K (+22.39 %) |
Nov 21 2018 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Payment of Exercise | F | 4.46 | 11,651 | 51,963 | 163,411 | 175.1 K to 163.4 K (-6.66 %) |
Oct 29 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 14,535 | 0 | 29,070 | |
Oct 29 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 14,535 | 0 | 252,591 | 238.1 K to 252.6 K (+6.11 %) |
Jul 26 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 14,534 | 0 | 43,605 | |
Jul 26 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 14,534 | 0 | 238,056 | 223.5 K to 238.1 K (+6.50 %) |
Jul 20 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 3,770 | 0 | 39,403 | 35.6 K to 39.4 K (+10.58 %) |
Jun 04 2018 | NVCR | NovoCure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 6,145 | 0 | 6,145 | |
Jun 04 2018 | NVCR | NovoCure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 31.45 | 12,345 | 388,250 | 12,345 | |
May 10 2018 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 31,250 | 0 | 31,250 | |
May 01 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Option Exercise | C | 0.00 | 35,924 | 0 | 0 | |
May 01 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Option Exercise | C | 0.00 | 44,905 | 0 | 0 | |
May 01 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Option Exercise | C | 0.00 | 8,981 | 0 | 0 | |
May 01 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Buy | C | 0.00 | 35,924 | 0 | 47,346 | 11.4 K to 47.3 K (+314.52 %) |
May 01 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Buy | C | 0.00 | 44,905 | 0 | 44,905 | 0 to 44.9 K |
May 01 2018 | DOCU | DOCUSIGN INC | LAVIGNE LOUIS J JR | Director | Buy | C | 0.00 | 8,981 | 0 | 35,633 | 26.7 K to 35.6 K (+33.70 %) |
Apr 27 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 58,139 | 0 | 58,139 | |
Apr 27 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 17,422 | 0 | 0 | |
Apr 27 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 17,422 | 0 | 223,522 | 206.1 K to 223.5 K (+8.45 %) |
Mar 15 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 17,421 | 0 | 17,422 | |
Mar 15 2018 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 17,421 | 0 | 206,100 | 188.7 K to 206.1 K (+9.23 %) |
Dec 04 2017 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 29,126 | 0 | 175,062 | 145.9 K to 175.1 K (+19.96 %) |
Nov 17 2017 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Payment of Exercise | F | 4.80 | 9,505 | 45,624 | 145,936 | 155.4 K to 145.9 K (-6.11 %) |
Nov 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 17,422 | 0 | 34,843 | |
Nov 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 17,422 | 0 | 188,679 | 171.3 K to 188.7 K (+10.17 %) |
Aug 16 2017 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 19,512 | 0 | 19,512 | |
Aug 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 17,421 | 0 | 52,265 | |
Aug 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 17,421 | 0 | 171,257 | 153.8 K to 171.3 K (+11.32 %) |
May 12 2017 | NVCR | Novocure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 12.30 | 23,600 | 290,280 | 23,600 | |
May 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 69,686 | 0 | 69,686 | |
May 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 19,084 | 0 | 0 | |
May 03 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 19,084 | 0 | 153,836 | 134.8 K to 153.8 K (+14.16 %) |
Mar 10 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 19,084 | 0 | 19,084 | |
Mar 10 2017 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 19,084 | 0 | 134,752 | 115.7 K to 134.8 K (+16.50 %) |
Dec 09 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 19,084 | 0 | 38,168 | |
Dec 09 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 19,084 | 0 | 115,668 | 96.6 K to 115.7 K (+19.76 %) |
Dec 02 2016 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 23,762 | 0 | 155,441 | 131.7 K to 155.4 K (+18.05 %) |
Nov 22 2016 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Payment of Exercise | F | 5.30 | 6,818 | 36,135 | 131,679 | 138.5 K to 131.7 K (-4.92 %) |
Sep 09 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 19,083 | 0 | 57,252 | |
Sep 09 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 19,083 | 0 | 96,584 | 77.5 K to 96.6 K (+24.62 %) |
Jun 13 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 76,335 | 0 | 76,335 | |
Jun 13 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 16,722 | 0 | 0 | |
Jun 13 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 16,722 | 0 | 77,501 | 60.8 K to 77.5 K (+27.51 %) |
May 20 2016 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 3,131 | 0 | 3,131 | |
May 20 2016 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 19.16 | 7,669 | 146,938 | 7,669 | |
May 13 2016 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Payment of Exercise | F | 17.52 | 1,035 | 18,133 | 4,403 | 5.4 K to 4.4 K (-19.03 %) |
May 06 2016 | NVCR | Novocure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 11.39 | 21,500 | 244,885 | 21,500 | |
Mar 15 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 16,722 | 0 | 16,722 | |
Mar 15 2016 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 16,722 | 0 | 60,799 | 44.1 K to 60.8 K (+37.94 %) |
Dec 15 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 16,722 | 0 | 33,444 | |
Dec 15 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 16,722 | 0 | 44,057 | 27.3 K to 44.1 K (+61.17 %) |
Dec 03 2015 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Payment of Exercise | F | 19.00 | 1,361 | 25,859 | 2,502 | 3.9 K to 2.5 K (-35.23 %) |
Dec 02 2015 | ARAY | ACCURAY INC | LAVIGNE LOUIS J JR | Director | Grant | A | 0.00 | 17,045 | 0 | 138,497 | 121.5 K to 138.5 K (+14.03 %) |
Oct 09 2015 | NVCR | Novocure Ltd | LAVIGNE LOUIS J JR | Director | Option Exercise | C | 0.00 | 7,403 | 0 | 0 | |
Oct 09 2015 | NVCR | Novocure Ltd | LAVIGNE LOUIS J JR | Director | Buy | C | 0.00 | 7,403 | 0 | 7,403 | 0 to 7.4 K |
Sep 15 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 16,723 | 0 | 50,166 | |
Sep 15 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 16,723 | 0 | 27,335 | 10.6 K to 27.3 K (+157.59 %) |
Jun 15 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 66,889 | 0 | 66,889 | |
Jun 11 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | M | 0.00 | 10,612 | 0 | 0 | |
Jun 11 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Buy | M | 0.00 | 10,612 | 0 | 10,612 | 0 to 10.6 K |
May 13 2015 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 2,936 | 0 | 2,936 | |
May 13 2015 | DMI | DEPOMED INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 20.43 | 7,857 | 160,519 | 7,857 | |
Apr 27 2015 | ZNGA | ZYNGA INC | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 0.00 | 10,612 | 0 | 10,612 | |
Mar 19 2015 | AGN | ALLERGAN INC | LAVIGNE LOUIS J JR | Director | Sell | D | 0.00 | 15,228 | 0 | 0 | 15.2 K to 0 (-100.00 %) |
Mar 19 2015 | AGN | ALLERGAN INC | LAVIGNE LOUIS J JR | Director | Sell | D | 0.00 | 2,920 | 0 | 0 | 2.9 K to 0 (-100.00 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,600 | 38,800 | 400,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,200 | 29,100 | 401,600 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 402,800 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 600 | 14,550 | 403,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 400 | 9,700 | 403,600 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,400 | 33,950 | 404,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.10 | 1,600 | 126,560 | 2,765 | 4.4 K to 2.8 K (-36.66 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,600 | 38,800 | 4,365 | 2.8 K to 4.4 K (+57.87 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.09 | 1,200 | 94,908 | 2,765 | 4 K to 2.8 K (-30.26 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,200 | 29,100 | 3,965 | 2.8 K to 4 K (+43.40 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.08 | 200 | 15,816 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.05 | 600 | 47,430 | 2,765 | 3.4 K to 2.8 K (-17.83 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 600 | 14,550 | 3,365 | 2.8 K to 3.4 K (+21.70 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.03 | 400 | 31,612 | 2,765 | 3.2 K to 2.8 K (-12.64 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 400 | 9,700 | 3,165 | 2.8 K to 3.2 K (+14.47 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.02 | 1,400 | 110,628 | 2,765 | 4.2 K to 2.8 K (-33.61 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,400 | 33,950 | 4,165 | 2.8 K to 4.2 K (+50.63 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,700 | 65,475 | 405,400 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 20,700 | 501,975 | 408,100 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 428,800 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 700 | 16,975 | 429,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,000 | 48,500 | 429,700 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,900 | 70,325 | 431,700 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 100 | 2,425 | 434,600 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 1,300 | 31,525 | 434,700 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 100 | 2,425 | 436,000 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 436,100 | |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.01 | 2,700 | 213,327 | 2,765 | 5.5 K to 2.8 K (-49.41 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,700 | 65,475 | 5,465 | 2.8 K to 5.5 K (+97.65 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 79.00 | 20,700 | 1,635,300 | 2,765 | 23.5 K to 2.8 K (-88.22 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 20,700 | 501,975 | 23,465 | 2.8 K to 23.5 K (+748.64 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.90 | 200 | 15,580 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.89 | 700 | 54,523 | 2,765 | 3.5 K to 2.8 K (-20.20 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 700 | 16,975 | 3,465 | 2.8 K to 3.5 K (+25.32 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.87 | 2,000 | 155,740 | 2,765 | 4.8 K to 2.8 K (-41.97 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,000 | 48,500 | 4,765 | 2.8 K to 4.8 K (+72.33 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.85 | 2,900 | 225,765 | 2,765 | 5.7 K to 2.8 K (-51.19 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 2,900 | 70,325 | 5,665 | 2.8 K to 5.7 K (+104.88 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.84 | 100 | 7,784 | 2,765 | 2.9 K to 2.8 K (-3.49 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 100 | 2,425 | 2,865 | 2.8 K to 2.9 K (+3.62 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.80 | 1,300 | 101,140 | 2,765 | 4.1 K to 2.8 K (-31.98 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 1,300 | 31,525 | 4,065 | 2.8 K to 4.1 K (+47.02 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.79 | 100 | 7,779 | 2,765 | 2.9 K to 2.8 K (-3.49 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 100 | 2,425 | 2,865 | 2.8 K to 2.9 K (+3.62 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Sell | S | 77.75 | 200 | 15,550 | 2,765 | 3 K to 2.8 K (-6.75 %) |
Jul 29 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Buy | M | 24.25 | 200 | 4,850 | 2,965 | 2.8 K to 3 K (+7.23 %) |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 436,300 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 2,700 | 65,475 | 436,500 | |
Jul 28 2003 | DNA | GENENTECH INC | LAVIGNE LOUIS J JR | EVP and CFO | Option Exercise | M | 24.25 | 200 | 4,850 | 439,200 |